Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2013

01.12.2013 | Original Article

Initial results from the newborn hearing screening programme in Ireland

verfasst von: A. O’Connor, P. G. O’Sullivan, L. Behan, G. Norman, B. Murphy

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Hearing screening programmes aim to detect hearing loss in the neonate. The Health Service Executive (HSE) South was the first phase of a national roll-out of a neonatal hearing screening programme in Ireland, going live on 28 April 2011.

Results

Over 11,738 babies have been screened for permanent childhood hearing impairment (PCHI) during the first 12 months. The percentage of eligible babies offered hearing screening was 99.2 %. Only 0.2 % (n = 25) of those offered screening declined. 493 (4 %) were referred for immediate diagnostic audiological assessment. The average time between screen and diagnostic audiology appointment was 2 weeks. 15 (1.3/1,000) babies have been identified with a PCHI over the 12-month period. 946 (4 %) babies screened were admitted to the neonatal intensive care unit (NICU) for >48 h. The prevalance of PCHI is 7.3/1,000 in the NICU population compared to 0.6/1000 in the well baby population. 214 (1.8 % of total babies screened) had a clear response in the screening programmes, but were deemed to be at risk of an acquired childhood hearing impairment. These babies will be reassessed with a diagnostic audiology appointment at 8–9 months of age. To date, there is one case of acquired hearing impairment through this targeted follow-up screen. Of the 15 cases of PCHI identified, 8 (53 %) of these had one or more risk factors for hearing loss and 7 (37 %) were admitted to the NICU for >48 h. Four babies were referred for assessment at the National Cochlear Implant Centre.
Fußnoten
1
Northgate eScreener Plus (eSP).
 
Literatur
1.
Zurück zum Zitat Fortum HM, Summerfield AQ, Marshall DH, Davis AC, Bamford JM (2001) Incidence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based assessment study. BMJ 323(7312):536–540CrossRef Fortum HM, Summerfield AQ, Marshall DH, Davis AC, Bamford JM (2001) Incidence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based assessment study. BMJ 323(7312):536–540CrossRef
2.
Zurück zum Zitat Yoshinaga-Itano C, Sedey AL (1998) Language of early and late identified children with hearing loss. Paediatrics 102:1161–1171CrossRef Yoshinaga-Itano C, Sedey AL (1998) Language of early and late identified children with hearing loss. Paediatrics 102:1161–1171CrossRef
3.
Zurück zum Zitat National Rehabilitation Board (1996) The epidemiology of childhood hearing impairment in South-East Ireland: implications for service providers. National Rehabilitation Board, Dublin National Rehabilitation Board (1996) The epidemiology of childhood hearing impairment in South-East Ireland: implications for service providers. National Rehabilitation Board, Dublin
4.
Zurück zum Zitat American academy of pediatrics (2007) Position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 106(4):798 American academy of pediatrics (2007) Position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 106(4):798
5.
Zurück zum Zitat Census (2011) Central Statistics Office, Dublin, Ireland Census (2011) Central Statistics Office, Dublin, Ireland
8.
Zurück zum Zitat Nikolopoulous TP, Archbold SM (1999) The development of auditory perception in children following cochlear implantation. Int J Pediatr Otorhinolaryngol 49:189–191CrossRef Nikolopoulous TP, Archbold SM (1999) The development of auditory perception in children following cochlear implantation. Int J Pediatr Otorhinolaryngol 49:189–191CrossRef
10.
Zurück zum Zitat Wilson JM (1968) The evaluation of the worth of early disease detection. J R Coll Gen Pract 16(Suppl 2):48–57PubMed Wilson JM (1968) The evaluation of the worth of early disease detection. J R Coll Gen Pract 16(Suppl 2):48–57PubMed
11.
Zurück zum Zitat Health service executive (2011) A practical guide to newborn bloodspot screening in Ireland, National newborn bloodspot screening laboratory, 5th edn. Children’s University Hospital, Dublin Health service executive (2011) A practical guide to newborn bloodspot screening in Ireland, National newborn bloodspot screening laboratory, 5th edn. Children’s University Hospital, Dublin
Metadaten
Titel
Initial results from the newborn hearing screening programme in Ireland
verfasst von
A. O’Connor
P. G. O’Sullivan
L. Behan
G. Norman
B. Murphy
Publikationsdatum
01.12.2013
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2013
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-013-0924-z

Weitere Artikel der Ausgabe 4/2013

Irish Journal of Medical Science (1971 -) 4/2013 Zur Ausgabe

Acknowledgement to Reviewers

Acknowledgement to reviewers

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.